Loading…
Effects of amisulpride and aripiprazole on progressive-ratio schedule performance: comparison with clozapine and haloperidol
Clozapine and some other atypical antipsychotics (e.g. quetiapine, olanzapine) have been found to exert a characteristic profile of action on operant behaviour maintained by progressive-ratio schedules, as revealed by Killeen’s Mathematical Principles of Reinforcement model of schedule-controlled be...
Saved in:
Published in: | Journal of psychopharmacology (Oxford) 2012-09, Vol.26 (9), p.1231-1243 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c398t-4240d26aa3705cbd9d22b51cf84b5387924033cc65fea004f5d924fc9e68f5253 |
---|---|
cites | cdi_FETCH-LOGICAL-c398t-4240d26aa3705cbd9d22b51cf84b5387924033cc65fea004f5d924fc9e68f5253 |
container_end_page | 1243 |
container_issue | 9 |
container_start_page | 1231 |
container_title | Journal of psychopharmacology (Oxford) |
container_volume | 26 |
creator | den Boon, FS Body, S Hampson, CL Bradshaw, CM Szabadi, E de Bruin, N |
description | Clozapine and some other atypical antipsychotics (e.g. quetiapine, olanzapine) have been found to exert a characteristic profile of action on operant behaviour maintained by progressive-ratio schedules, as revealed by Killeen’s Mathematical Principles of Reinforcement model of schedule-controlled behaviour. These drugs increase the value of a parameter that expresses the ‘incentive value’ of the reinforcer (a) and a parameter that is inversely related to the organism’s ‘motor capacity’ (δ). This experiment examined the effects of two further atypical antipsychotics, aripiprazole and amisulpride, on progressive-ratio schedule performance in rats; the effects of clozapine and a conventional antipsychotic, haloperidol, were also examined. In agreement with previous findings, clozapine (4, 8 mg kg−1) increased a and δ, whereas haloperidol (0.05, 0.1 mg kg−1) reduced a and increased δ. Aripiprazole (3,30 mg kg−1) increased δ but did not affect a. Amisulpride (5, 50 mg kg−1) had a delayed and protracted effect: δ was increased 3–6 hours after treatment; a was increased 1.5 hours, and reduced 12–24 hours after treatment. Interpretation based on Killeen’s model suggests that aripiprazole does not share clozapine’s ability to enhance reinforcer value. Amisulpride produced a short-lived enhancement, followed by a long-lasting reduction, of reinforcer value. Both drugs impaired motor performance. |
doi_str_mv | 10.1177/0269881111421974 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1034811880</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_0269881111421974</sage_id><sourcerecordid>1031156542</sourcerecordid><originalsourceid>FETCH-LOGICAL-c398t-4240d26aa3705cbd9d22b51cf84b5387924033cc65fea004f5d924fc9e68f5253</originalsourceid><addsrcrecordid>eNqNkUFrFTEUhYMo9rW6dyUBN26mJpkkk-lOSm0LBTe6HvKSm76Umck0mbG09Md7h1dFCgWzCeR854R7LiEfODvmvGm-MKFbYzgeKXjbyFdkw6XmVSOMek02q1yt-gE5LOWGMa6lVm_JAcK65UxtyONZCODmQlOgdohl6accPVA7empznOKU7UPqgaaRTjldZygl_oIq2zkmWtwO_ILqBDmkPNjRwQl1aZjQW9ByF-cddX16sFMc96k72yfEo0_9O_Im2L7A-6f7iPz8dvbj9KK6-n5-efr1qnJ1a-ZKCsm80NbWDVNu61svxFZxF4zcqto0Lep17ZxWASxjMiiPT8G1oE1QQtVH5PM-Fye4XaDMHU7qoO_tCGkpHWe1xJaMYf-Dcq60kgLRT8_Qm7TkEQdZKYFdG70Gsj3lciolQ-iw4MHme4S6dYnd8yWi5eNT8LIdwP81_NkaAtUeKPYa_v31hcDf03ykuw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1032164860</pqid></control><display><type>article</type><title>Effects of amisulpride and aripiprazole on progressive-ratio schedule performance: comparison with clozapine and haloperidol</title><source>SAGE</source><creator>den Boon, FS ; Body, S ; Hampson, CL ; Bradshaw, CM ; Szabadi, E ; de Bruin, N</creator><creatorcontrib>den Boon, FS ; Body, S ; Hampson, CL ; Bradshaw, CM ; Szabadi, E ; de Bruin, N</creatorcontrib><description>Clozapine and some other atypical antipsychotics (e.g. quetiapine, olanzapine) have been found to exert a characteristic profile of action on operant behaviour maintained by progressive-ratio schedules, as revealed by Killeen’s Mathematical Principles of Reinforcement model of schedule-controlled behaviour. These drugs increase the value of a parameter that expresses the ‘incentive value’ of the reinforcer (a) and a parameter that is inversely related to the organism’s ‘motor capacity’ (δ). This experiment examined the effects of two further atypical antipsychotics, aripiprazole and amisulpride, on progressive-ratio schedule performance in rats; the effects of clozapine and a conventional antipsychotic, haloperidol, were also examined. In agreement with previous findings, clozapine (4, 8 mg kg−1) increased a and δ, whereas haloperidol (0.05, 0.1 mg kg−1) reduced a and increased δ. Aripiprazole (3,30 mg kg−1) increased δ but did not affect a. Amisulpride (5, 50 mg kg−1) had a delayed and protracted effect: δ was increased 3–6 hours after treatment; a was increased 1.5 hours, and reduced 12–24 hours after treatment. Interpretation based on Killeen’s model suggests that aripiprazole does not share clozapine’s ability to enhance reinforcer value. Amisulpride produced a short-lived enhancement, followed by a long-lasting reduction, of reinforcer value. Both drugs impaired motor performance.</description><identifier>ISSN: 0269-8811</identifier><identifier>EISSN: 1461-7285</identifier><identifier>DOI: 10.1177/0269881111421974</identifier><identifier>PMID: 21969105</identifier><identifier>CODEN: JOPSEQ</identifier><language>eng</language><publisher>London, England: SAGE Publications</publisher><subject><![CDATA[Animals ; Antipsychotic Agents - administration & dosage ; Antipsychotic Agents - adverse effects ; Antipsychotic Agents - pharmacology ; Aripiprazole ; Behavior, Animal - drug effects ; Clozapine ; Clozapine - administration & dosage ; Clozapine - adverse effects ; Clozapine - pharmacology ; Conditioning, Operant - drug effects ; Dopamine Antagonists - administration & dosage ; Dopamine Antagonists - adverse effects ; Dopamine Antagonists - pharmacology ; Dose-Response Relationship, Drug ; Drugs ; Female ; Haloperidol ; Haloperidol - administration & dosage ; Haloperidol - adverse effects ; Haloperidol - pharmacology ; Kinetics ; Mathematical models ; Medical treatment ; Models, Biological ; Motor Activity - drug effects ; Motor Skills - drug effects ; Motor task performance ; Neuroleptics ; olanzapine ; Operant conditioning ; Piperazines - administration & dosage ; Piperazines - adverse effects ; Piperazines - pharmacology ; Psychopharmacology ; Psychotropic drugs ; quetiapine ; Quinolones - administration & dosage ; Quinolones - adverse effects ; Quinolones - pharmacology ; Rats ; Rats, Wistar ; Reaction Time - drug effects ; Reinforcement ; Reinforcement Schedule ; Rodents ; Serotonin Antagonists - administration & dosage ; Serotonin Antagonists - adverse effects ; Serotonin Antagonists - pharmacology ; Sulpiride - administration & dosage ; Sulpiride - adverse effects ; Sulpiride - analogs & derivatives ; Sulpiride - pharmacology]]></subject><ispartof>Journal of psychopharmacology (Oxford), 2012-09, Vol.26 (9), p.1231-1243</ispartof><rights>The Author(s) 2012</rights><rights>Copyright Sage Publications Ltd. Sep 2012</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c398t-4240d26aa3705cbd9d22b51cf84b5387924033cc65fea004f5d924fc9e68f5253</citedby><cites>FETCH-LOGICAL-c398t-4240d26aa3705cbd9d22b51cf84b5387924033cc65fea004f5d924fc9e68f5253</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925,79364</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21969105$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>den Boon, FS</creatorcontrib><creatorcontrib>Body, S</creatorcontrib><creatorcontrib>Hampson, CL</creatorcontrib><creatorcontrib>Bradshaw, CM</creatorcontrib><creatorcontrib>Szabadi, E</creatorcontrib><creatorcontrib>de Bruin, N</creatorcontrib><title>Effects of amisulpride and aripiprazole on progressive-ratio schedule performance: comparison with clozapine and haloperidol</title><title>Journal of psychopharmacology (Oxford)</title><addtitle>J Psychopharmacol</addtitle><description>Clozapine and some other atypical antipsychotics (e.g. quetiapine, olanzapine) have been found to exert a characteristic profile of action on operant behaviour maintained by progressive-ratio schedules, as revealed by Killeen’s Mathematical Principles of Reinforcement model of schedule-controlled behaviour. These drugs increase the value of a parameter that expresses the ‘incentive value’ of the reinforcer (a) and a parameter that is inversely related to the organism’s ‘motor capacity’ (δ). This experiment examined the effects of two further atypical antipsychotics, aripiprazole and amisulpride, on progressive-ratio schedule performance in rats; the effects of clozapine and a conventional antipsychotic, haloperidol, were also examined. In agreement with previous findings, clozapine (4, 8 mg kg−1) increased a and δ, whereas haloperidol (0.05, 0.1 mg kg−1) reduced a and increased δ. Aripiprazole (3,30 mg kg−1) increased δ but did not affect a. Amisulpride (5, 50 mg kg−1) had a delayed and protracted effect: δ was increased 3–6 hours after treatment; a was increased 1.5 hours, and reduced 12–24 hours after treatment. Interpretation based on Killeen’s model suggests that aripiprazole does not share clozapine’s ability to enhance reinforcer value. Amisulpride produced a short-lived enhancement, followed by a long-lasting reduction, of reinforcer value. Both drugs impaired motor performance.</description><subject>Animals</subject><subject>Antipsychotic Agents - administration & dosage</subject><subject>Antipsychotic Agents - adverse effects</subject><subject>Antipsychotic Agents - pharmacology</subject><subject>Aripiprazole</subject><subject>Behavior, Animal - drug effects</subject><subject>Clozapine</subject><subject>Clozapine - administration & dosage</subject><subject>Clozapine - adverse effects</subject><subject>Clozapine - pharmacology</subject><subject>Conditioning, Operant - drug effects</subject><subject>Dopamine Antagonists - administration & dosage</subject><subject>Dopamine Antagonists - adverse effects</subject><subject>Dopamine Antagonists - pharmacology</subject><subject>Dose-Response Relationship, Drug</subject><subject>Drugs</subject><subject>Female</subject><subject>Haloperidol</subject><subject>Haloperidol - administration & dosage</subject><subject>Haloperidol - adverse effects</subject><subject>Haloperidol - pharmacology</subject><subject>Kinetics</subject><subject>Mathematical models</subject><subject>Medical treatment</subject><subject>Models, Biological</subject><subject>Motor Activity - drug effects</subject><subject>Motor Skills - drug effects</subject><subject>Motor task performance</subject><subject>Neuroleptics</subject><subject>olanzapine</subject><subject>Operant conditioning</subject><subject>Piperazines - administration & dosage</subject><subject>Piperazines - adverse effects</subject><subject>Piperazines - pharmacology</subject><subject>Psychopharmacology</subject><subject>Psychotropic drugs</subject><subject>quetiapine</subject><subject>Quinolones - administration & dosage</subject><subject>Quinolones - adverse effects</subject><subject>Quinolones - pharmacology</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Reaction Time - drug effects</subject><subject>Reinforcement</subject><subject>Reinforcement Schedule</subject><subject>Rodents</subject><subject>Serotonin Antagonists - administration & dosage</subject><subject>Serotonin Antagonists - adverse effects</subject><subject>Serotonin Antagonists - pharmacology</subject><subject>Sulpiride - administration & dosage</subject><subject>Sulpiride - adverse effects</subject><subject>Sulpiride - analogs & derivatives</subject><subject>Sulpiride - pharmacology</subject><issn>0269-8811</issn><issn>1461-7285</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNqNkUFrFTEUhYMo9rW6dyUBN26mJpkkk-lOSm0LBTe6HvKSm76Umck0mbG09Md7h1dFCgWzCeR854R7LiEfODvmvGm-MKFbYzgeKXjbyFdkw6XmVSOMek02q1yt-gE5LOWGMa6lVm_JAcK65UxtyONZCODmQlOgdohl6accPVA7empznOKU7UPqgaaRTjldZygl_oIq2zkmWtwO_ILqBDmkPNjRwQl1aZjQW9ByF-cddX16sFMc96k72yfEo0_9O_Im2L7A-6f7iPz8dvbj9KK6-n5-efr1qnJ1a-ZKCsm80NbWDVNu61svxFZxF4zcqto0Lep17ZxWASxjMiiPT8G1oE1QQtVH5PM-Fye4XaDMHU7qoO_tCGkpHWe1xJaMYf-Dcq60kgLRT8_Qm7TkEQdZKYFdG70Gsj3lciolQ-iw4MHme4S6dYnd8yWi5eNT8LIdwP81_NkaAtUeKPYa_v31hcDf03ykuw</recordid><startdate>201209</startdate><enddate>201209</enddate><creator>den Boon, FS</creator><creator>Body, S</creator><creator>Hampson, CL</creator><creator>Bradshaw, CM</creator><creator>Szabadi, E</creator><creator>de Bruin, N</creator><general>SAGE Publications</general><general>Sage Publications Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7X8</scope></search><sort><creationdate>201209</creationdate><title>Effects of amisulpride and aripiprazole on progressive-ratio schedule performance: comparison with clozapine and haloperidol</title><author>den Boon, FS ; Body, S ; Hampson, CL ; Bradshaw, CM ; Szabadi, E ; de Bruin, N</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c398t-4240d26aa3705cbd9d22b51cf84b5387924033cc65fea004f5d924fc9e68f5253</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Animals</topic><topic>Antipsychotic Agents - administration & dosage</topic><topic>Antipsychotic Agents - adverse effects</topic><topic>Antipsychotic Agents - pharmacology</topic><topic>Aripiprazole</topic><topic>Behavior, Animal - drug effects</topic><topic>Clozapine</topic><topic>Clozapine - administration & dosage</topic><topic>Clozapine - adverse effects</topic><topic>Clozapine - pharmacology</topic><topic>Conditioning, Operant - drug effects</topic><topic>Dopamine Antagonists - administration & dosage</topic><topic>Dopamine Antagonists - adverse effects</topic><topic>Dopamine Antagonists - pharmacology</topic><topic>Dose-Response Relationship, Drug</topic><topic>Drugs</topic><topic>Female</topic><topic>Haloperidol</topic><topic>Haloperidol - administration & dosage</topic><topic>Haloperidol - adverse effects</topic><topic>Haloperidol - pharmacology</topic><topic>Kinetics</topic><topic>Mathematical models</topic><topic>Medical treatment</topic><topic>Models, Biological</topic><topic>Motor Activity - drug effects</topic><topic>Motor Skills - drug effects</topic><topic>Motor task performance</topic><topic>Neuroleptics</topic><topic>olanzapine</topic><topic>Operant conditioning</topic><topic>Piperazines - administration & dosage</topic><topic>Piperazines - adverse effects</topic><topic>Piperazines - pharmacology</topic><topic>Psychopharmacology</topic><topic>Psychotropic drugs</topic><topic>quetiapine</topic><topic>Quinolones - administration & dosage</topic><topic>Quinolones - adverse effects</topic><topic>Quinolones - pharmacology</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Reaction Time - drug effects</topic><topic>Reinforcement</topic><topic>Reinforcement Schedule</topic><topic>Rodents</topic><topic>Serotonin Antagonists - administration & dosage</topic><topic>Serotonin Antagonists - adverse effects</topic><topic>Serotonin Antagonists - pharmacology</topic><topic>Sulpiride - administration & dosage</topic><topic>Sulpiride - adverse effects</topic><topic>Sulpiride - analogs & derivatives</topic><topic>Sulpiride - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>den Boon, FS</creatorcontrib><creatorcontrib>Body, S</creatorcontrib><creatorcontrib>Hampson, CL</creatorcontrib><creatorcontrib>Bradshaw, CM</creatorcontrib><creatorcontrib>Szabadi, E</creatorcontrib><creatorcontrib>de Bruin, N</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of psychopharmacology (Oxford)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>den Boon, FS</au><au>Body, S</au><au>Hampson, CL</au><au>Bradshaw, CM</au><au>Szabadi, E</au><au>de Bruin, N</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of amisulpride and aripiprazole on progressive-ratio schedule performance: comparison with clozapine and haloperidol</atitle><jtitle>Journal of psychopharmacology (Oxford)</jtitle><addtitle>J Psychopharmacol</addtitle><date>2012-09</date><risdate>2012</risdate><volume>26</volume><issue>9</issue><spage>1231</spage><epage>1243</epage><pages>1231-1243</pages><issn>0269-8811</issn><eissn>1461-7285</eissn><coden>JOPSEQ</coden><abstract>Clozapine and some other atypical antipsychotics (e.g. quetiapine, olanzapine) have been found to exert a characteristic profile of action on operant behaviour maintained by progressive-ratio schedules, as revealed by Killeen’s Mathematical Principles of Reinforcement model of schedule-controlled behaviour. These drugs increase the value of a parameter that expresses the ‘incentive value’ of the reinforcer (a) and a parameter that is inversely related to the organism’s ‘motor capacity’ (δ). This experiment examined the effects of two further atypical antipsychotics, aripiprazole and amisulpride, on progressive-ratio schedule performance in rats; the effects of clozapine and a conventional antipsychotic, haloperidol, were also examined. In agreement with previous findings, clozapine (4, 8 mg kg−1) increased a and δ, whereas haloperidol (0.05, 0.1 mg kg−1) reduced a and increased δ. Aripiprazole (3,30 mg kg−1) increased δ but did not affect a. Amisulpride (5, 50 mg kg−1) had a delayed and protracted effect: δ was increased 3–6 hours after treatment; a was increased 1.5 hours, and reduced 12–24 hours after treatment. Interpretation based on Killeen’s model suggests that aripiprazole does not share clozapine’s ability to enhance reinforcer value. Amisulpride produced a short-lived enhancement, followed by a long-lasting reduction, of reinforcer value. Both drugs impaired motor performance.</abstract><cop>London, England</cop><pub>SAGE Publications</pub><pmid>21969105</pmid><doi>10.1177/0269881111421974</doi><tpages>13</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0269-8811 |
ispartof | Journal of psychopharmacology (Oxford), 2012-09, Vol.26 (9), p.1231-1243 |
issn | 0269-8811 1461-7285 |
language | eng |
recordid | cdi_proquest_miscellaneous_1034811880 |
source | SAGE |
subjects | Animals Antipsychotic Agents - administration & dosage Antipsychotic Agents - adverse effects Antipsychotic Agents - pharmacology Aripiprazole Behavior, Animal - drug effects Clozapine Clozapine - administration & dosage Clozapine - adverse effects Clozapine - pharmacology Conditioning, Operant - drug effects Dopamine Antagonists - administration & dosage Dopamine Antagonists - adverse effects Dopamine Antagonists - pharmacology Dose-Response Relationship, Drug Drugs Female Haloperidol Haloperidol - administration & dosage Haloperidol - adverse effects Haloperidol - pharmacology Kinetics Mathematical models Medical treatment Models, Biological Motor Activity - drug effects Motor Skills - drug effects Motor task performance Neuroleptics olanzapine Operant conditioning Piperazines - administration & dosage Piperazines - adverse effects Piperazines - pharmacology Psychopharmacology Psychotropic drugs quetiapine Quinolones - administration & dosage Quinolones - adverse effects Quinolones - pharmacology Rats Rats, Wistar Reaction Time - drug effects Reinforcement Reinforcement Schedule Rodents Serotonin Antagonists - administration & dosage Serotonin Antagonists - adverse effects Serotonin Antagonists - pharmacology Sulpiride - administration & dosage Sulpiride - adverse effects Sulpiride - analogs & derivatives Sulpiride - pharmacology |
title | Effects of amisulpride and aripiprazole on progressive-ratio schedule performance: comparison with clozapine and haloperidol |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T13%3A23%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%20amisulpride%20and%20aripiprazole%20on%20progressive-ratio%20schedule%20performance:%20comparison%20with%20clozapine%20and%20haloperidol&rft.jtitle=Journal%20of%20psychopharmacology%20(Oxford)&rft.au=den%20Boon,%20FS&rft.date=2012-09&rft.volume=26&rft.issue=9&rft.spage=1231&rft.epage=1243&rft.pages=1231-1243&rft.issn=0269-8811&rft.eissn=1461-7285&rft.coden=JOPSEQ&rft_id=info:doi/10.1177/0269881111421974&rft_dat=%3Cproquest_cross%3E1031156542%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c398t-4240d26aa3705cbd9d22b51cf84b5387924033cc65fea004f5d924fc9e68f5253%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1032164860&rft_id=info:pmid/21969105&rft_sage_id=10.1177_0269881111421974&rfr_iscdi=true |